Diablo Clinical Research

Recent papers from Diablo Clinical Research

1. Clinical outcomes of a digitally delivered structured lifestyle program in type 2 diabetes: a randomized controlled trial from IndiaFrontiers in Endocrinology · 2026
2. Understanding COPD Patients’ Perspectives on Utilizing Strategies to Limit Their Exposure to Wildfire SmokeChronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 2026
3. Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years.2026
4. Accuracy of the 15.5-Day G7 iCGM in Adults with DiabetesDiabetes Technology & Therapeutics · 2025
5. We are the children of one mother: A cypher on abolition and apocalyptic educationCurriculum Inquiry · 2025
6. Remote Sensing Technologies Quantify the Contribution of Ambient Air Pollution to Asthma Severity and Risk Factors in Greenness, Air Pollution, and Wildfire Ecological Settings: A Literature ReviewAtmosphere · 2024
7. Resurrecting an Abandoned Potable Water Pipeline SystemPipelines 2017 · 2024
8. A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine–Experienced Adults 50 Years of Age or Older (STRIDE-6)Clinical Infectious Diseases · 2024
9. Case report: Long-term follow-up of patients who received a FimCH vaccine for prevention of recurrent urinary tract infections caused by antibiotic resistant Enterobacteriaceae: a case report seriesFrontiers in Immunology · 2024
10. Differences in eConsent among diagnosis groupsContemporary Clinical Trials Communications · 2023
11. Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorDiabetes Technology & Therapeutics · 2023
12. Inflammation Describes and Explains the Adverse Effects of Aerosol Optical Depth-Particulate Matter on Cardiovascular Outcomes: A Literature Review Since 2012Medical Research Archives · 2023
13. Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled TrialDiabetes Technology & Therapeutics · 2022
14. Reduction in Postprandial Peak Glucose With Increased Technosphere Insulin DosageJournal of Diabetes Science and Technology · 2022
15. New Homogeneous Spatial Areas Identified Using Case-Crossover Spatial Lag Grid Differences between Aerosol Optical Depth-PM2.5 and Respiratory-Cardiovascular Emergency Department Visits and HospitalizationsAtmosphere · 2022
16. Accuracy of a Seventh-Generation Continuous Glucose Monitoring System in Children and Adolescents With Type 1 DiabetesJournal of Diabetes Science and Technology · 2022
17. Case-Crossover Spatial Lag Grid Differences Between Aerosol Optical Depth-PM2.5 and Respiratory-Cardiovascular Emergency Department Visits and Inpatient Hospitalizations in Baltimore, Maryland, USA: Identification of Homogeneous Spatial Areas2022
18. Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready‐to‐use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin‐induced severe hypoglycaemia in adults with type 1 diabetesDiabetes Obesity and Metabolism · 2022
19. Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with DiabetesDiabetes Technology & Therapeutics · 2022
20. Case-Crossover Spatial Lag Grid Differences Between Aerosol Optical Depth-PM2.5 and Respiratory-Cardiovascular Emergency Department Visits and Inpatient Hospitalizations in Baltimore, Maryland, USA: Identification of Homogeneous Spatial Areas2022